Business

Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

Mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditionsSupported by Health Moonshot Champions, including the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates VenturesApollo House, the Founders & Funders Networking Summit, to bring together founders, funders and industry leaders addressing Health Moonshots worldwideLongeveron will also be hosting meetings with institutional investors and potential partners during the

articleLongeveron Inc.December 29, 20255/company/longeveron-llc/news/longeveron-selected-startup-health-alzheimer-141500064
Longeveron, Selected as a StartUp Health Alzheimer’s Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

About this update from Longeveron Inc.

[{"type":"image","alt":"Longeveron","displaySize":"","headline":null,"caption":"Longeveron","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":56,"url":"https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.X2J.blw.0f9XkdGnRbwAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/7020f3e4e4ad01a05af1150b74d0406a","width":300,"height":56}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditions","length":130,"tagName":"p"}]},{"val":[{"type":"text","content":"Supported by Health Moonshot Champions, including the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures","length":117,"tagName":"p"}]},{"val":[{"type":"text","content":"Apollo House, the Founders & Funders Networking Summit, to bring together founders, funders and industry leaders addressing Health Moonshots worldwide","length":154,"tagName":"p"}]},{"val":[{"type":"text","content":"Longeveron will also be hosting meetings with institutional investors and potential partners during the week","length":108,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":509,"olType":false},{"type":"text","content":"MIAMI, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that, as a StartUp Health Alzheimer’s & Brain Health Moonshot company, it will be participating in StartUp Health Apollo House during JPM Healthcare Week in January 2026.","length":405,"tagName":"p"},{"type":"text","content":"StartUp Health Alzheimer’s & Brain Moonshot is a mission-aligned community focused on accelerating breakthroughs in Alzheimer’s disease, Parkinson’s disease and related conditions, supported by Health Moonshot Champions, including the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures. Apollo House, the Founders & Funders Networking Summit, is intended to bring together founders, funders and industry leaders addressing Health Moonshots worldwide.","length":471,"tagName":"p"},{"type":"text","content":"Longeveron...

More updates from Longeveron Inc.

Alzheimer’sThe CompanyLongeveron Inc.Apollo HouseAlzheimer’s Drug Discovery FoundationHealth Moonshot ChampionsParkinson’s diseaseStartUp Healthinvestigational productPediatric Dilated Cardiomyopathybiotechnology company